The prostate question
For years men were warned that testosterone causes prostate cancer. Current evidence doesn't support that claim. What's true is that testosterone can stimulate existing prostate tissue, so PSA and prostate health are monitored throughout therapy — routine territory for a urologist, and one reason this care belongs with a specialist.
The heart question
Cardiovascular safety has been studied intensively, and recent large trials have been reassuring when therapy is properly managed. The known cardiovascular risk isn't testosterone itself so much as an uncontrolled rise in red blood cell count, which thickens the blood — and that is exactly what routine bloodwork catches early.
What monitoring actually does
This is the entire case for doing TRT with a physician. Regular labs catch a rising red blood cell count, track PSA, and keep estrogen in range — before any of it becomes a problem. It's the difference between supervised therapy and a mail-order vial. See our full safety and monitoring guide.
The bottom line
For appropriate, monitored candidates, TRT is safe. Nearly every serious risk traces back to therapy without oversight — which is the one thing AndroMD never skips.